Hepatic 31P magnetic resonance spectroscopy: a hepatologist's user guide (Q36135498)

12 August 2017

1 reference

title

Hepatic 31P magnetic resonance spectroscopy: a hepatologist's user guide (English)

1 reference

12 August 2017

Steven F Solga

1

1 reference

12 August 2017

Alena Horska

series ordinal

2

1 reference

12 August 2017

Jeanne M Clark

series ordinal

3

1 reference

12 August 2017

Anna Mae Diehl

series ordinal

4

1 reference

12 August 2017

publication date

1 June 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

25

1 reference

12 August 2017

issue

3

1 reference

12 August 2017

page(s)

490-500

1 reference

Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01131.X

Nuclear magnetic resonance studies of hepatic glucose metabolism in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01131.X

Optimization of localized 19F magnetic resonance spectroscopy for the detection of fluorinated drugs in the human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01131.X

A 31P and 1H-NMR investigation in vitro of normal and abnormal human liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01131.X

The 31P NMR visibility of ATP in perfused rat liver remains about 90%, unaffected by changes of metabolic state

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01131.X

Phosphorus-31 nuclear-magnetic-resonance study of phosphorylated metabolites compartmentation, intracellular pH and phosphorylation state during normoxia, hypoxia and ethanol perfusion, in the perfused rat liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01131.X

Non-T1-weighted 31P chemical shift imaging of the human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01131.X

Understanding the discrepancies between 31P MR spectroscopy assessed liver metabolite concentrations from different institutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01131.X

Prior knowledge for time domain quantification of in vivo brain or liver 31P MR spectra

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01131.X

Phosphomonoester is associated with proliferation in human breast cancer: a 31P MRS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01131.X

Effects of oral D-tagatose, a stereoisomer of D-fructose, on liver metabolism in man as examined by 31P-magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01131.X

In vivo monitoring of fructose metabolism in the human liver by means of 31P magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01131.X

Effects of ATP infusion on glucose turnover and gluconeogenesis in patients with advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01131.X

Adenosine triphosphate infusion increases liver energy status in advanced lung cancer patients: an in vivo 31P magnetic resonance spectroscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01131.X

10.1111/J.1478-3231.2005.01131.X

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference